TIGIT inhibitor M6223 as monotherapy or in combination with bintrafusp alfa in patients with advanced solid tumors: a first-in-human, phase 1, dose-escalation trial
TIGIT抑制剂M6223单药治疗或与bintrafusp alfa联合治疗晚期实体瘤患者:一项首次人体I期剂量递增试验
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2024-010584
Naing, Aung; McKean, Meredith; Tolcher, Anthony; Victor, Anja; Hu, Ping; Gao, Wei; Nogueira Filho, Marco A F; Kitzing, Thomas; Gleicher, Stephan; Holland, Daniel; Richter, Emilia; Tadjalli-Mehr, Keyvan; Siu, Lillian L